Kathryn J. Newhall

Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study

M. Lia Palomba, Leo I. Gordon, Matthew A. Lunning et al. · The Lancet · 2020 · 2.3K citations

Medicine, Oncology, Pharmacology +13

Cellular determinants for preclinical activity of a novel CD33/CD3 bispecific T-cell engager (BiTE) antibody, AMG 330, against human AML

George S. Laszlo, Chelsea J. Gudgeon, Kimberly H. Harrington et al. · Blood · 2013 · 173 citations · Full text

Life Sciences, Immunology, Oncology +14

Dynamic Anchoring of PKA Is Essential during Oocyte Maturation

Kathryn J. Newhall, Amy Criniti, Christine S. Cheah et al. · Current Biology · 2006 · 116 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +12

Mutations Affecting the SAND Domain of DEAF1 Cause Intellectual Disability with Severe Speech Impairment and Behavioral Problems

Anneke T. Vulto‐van Silfhout, Shivakumar Rajamanickam, Philip J. Jensik et al. · The American Journal of Human Genetics · 2014 · 68 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

The Broad Anti-AML Activity of the CD33/CD3 BiTE Antibody Construct, AMG 330, Is Impacted by Disease Stage and Risk

Kimberly H. Harrington, Chelsea J. Gudgeon, George S. Laszlo et al. · PLoS ONE · 2015 · 61 citations · Full text

Life Sciences, Hematology, Immunology +16